Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1974-5-2
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0040-5922
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
49
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
349-54
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:4592771-Ambulatory Care,
pubmed-meshheading:4592771-Benzodiazepinones,
pubmed-meshheading:4592771-Clinical Trials as Topic,
pubmed-meshheading:4592771-Female,
pubmed-meshheading:4592771-Humans,
pubmed-meshheading:4592771-Male,
pubmed-meshheading:4592771-Neurotic Disorders,
pubmed-meshheading:4592771-Psychotic Disorders,
pubmed-meshheading:4592771-Tranquilizing Agents
|
pubmed:articleTitle |
[A new tranquilizer: lorazepam (158 cases)].
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Controlled Clinical Trial
|